- Stocks
- Healthcare
- NASDAQ: BRKR

Price (delayed)

$78.05

Market cap

$10.75B

P/E Ratio

26.73

Dividend/share

$0.2

EPS

$2.92

Enterprise value

$11.61B

Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker's high-performance scienti c instruments and high-value analytical and diagnostic solutions

BRKR's EPS is up by 46% year-on-year and by 35% since the previous quarter

The net income is up by 44% year-on-year and by 34% since the previous quarter

The quick ratio has decreased by 33% YoY but it has increased by 13% from the previous quarter

Bruker's debt has increased by 11% from the previous quarter and by 8% YoY

What are the main financial stats of BRKR

Market
Valuations
Earnings

Shares outstanding

137.67M

Market cap

$10.75B

Enterprise value

$11.61B

Price to earnings (P/E)

26.73

Price to book (P/B)

7.84

Price to sales (P/S)

3.85

EV/EBIT

21.31

EV/EBITDA

17.6

EV/Sales

3.92

Revenue

$2.96B

EBIT

$544.9M

EBITDA

$659.8M

Free cash flow

$254.3M

Per share
Balance sheet
Liquidity

EPS

$2.92

Free cash flow per share

$1.74

Book value per share

$9.95

Revenue per share

$20.25

TBVPS

$22.79

Total assets

$4.25B

Total liabilities

$2.84B

Debt

$1.36B

Equity

$1.38B

Working capital

$962.1M

Debt to equity

0.98

Current ratio

1.8

Quick ratio

0.89

Net debt/EBITDA

1.32

Margins
Efficiency
Dividend

EBITDA margin

22.3%

Gross margin

51%

Net margin

14.4%

Operating margin

14.7%

Return on assets

10.9%

Return on equity

34.2%

Return on invested capital

20%

Return on capital employed

17.9%

Return on sales

18.4%

Dividend yield

0.26%

DPS

$0.2

Payout ratio

6.8%

How has the Bruker stock price performed over time

Intraday

0.37%

1 week

-8.98%

1 month

-16.88%

1 year

-4.13%

YTD

6.22%

QTD

-16.92%

How have Bruker's revenue and profit performed over time

Revenue

$2.96B

Gross profit

$1.51B

Operating income

$436.9M

Net income

$427.2M

Gross margin

51%

Net margin

14.4%

The net income is up by 44% year-on-year and by 34% since the previous quarter

Bruker's net margin has increased by 27% from the previous quarter and by 23% YoY

Bruker's revenue has increased by 17% YoY and by 5% QoQ

BRKR's gross profit is up by 16% year-on-year and by 4.4% since the previous quarter

What is Bruker's growth rate over time

What is Bruker stock price valuation

P/E

26.73

P/B

7.84

P/S

3.85

EV/EBIT

21.31

EV/EBITDA

17.6

EV/Sales

3.92

BRKR's EPS is up by 46% year-on-year and by 35% since the previous quarter

BRKR's price to earnings (P/E) is 29% lower than its 5-year quarterly average of 37.9 and 15% lower than its last 4 quarters average of 31.3

BRKR's equity is up by 24% YoY and by 14% QoQ

The stock's price to book (P/B) is 12% less than its 5-year quarterly average of 8.9 and 7% less than its last 4 quarters average of 8.4

Bruker's revenue has increased by 17% YoY and by 5% QoQ

How efficient is Bruker business performance

BRKR's return on assets is up by 28% since the previous quarter and by 28% year-on-year

Bruker's return on equity has increased by 27% QoQ and by 16% YoY

BRKR's return on sales is up by 23% since the previous quarter and by 13% year-on-year

Bruker's return on invested capital has increased by 23% QoQ and by 19% YoY

What is BRKR's dividend history

DPS

$0.2

Dividend yield

0.26%

Payout ratio

6.8%

Recent dividends

How did Bruker financials performed over time

BRKR's total assets is 50% greater than its total liabilities

The quick ratio has decreased by 33% YoY but it has increased by 13% from the previous quarter

BRKR's current ratio is down by 22% year-on-year and by 4.8% since the previous quarter

BRKR's equity is up by 24% YoY and by 14% QoQ

BRKR's debt to equity is down by 13% year-on-year and by 3% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.